Trials / Completed
CompletedNCT02342795
Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 520 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to use Randomized Controlled Trial (RCT) methods to examine the influence of novel tobacco products on biomarkers of toxicant exposure and disease risk, reports of adverse events, and concurrent use of other tobacco products. In this case, the novel products are one type of electronic cigarette and an imitation cigarette or cigarette substitute.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | e-cigarette | |
| OTHER | cigarette substitute |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2018-06-01
- Completion
- 2018-07-01
- First posted
- 2015-01-21
- Last updated
- 2018-09-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02342795. Inclusion in this directory is not an endorsement.